You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Area Under the Curve (AUC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Receiving MMF for Diffuse Cutaneous or Pulmonary

Recruiting
  • Systemic Sclerosis
  • AUC of MPA measure
  • Paris, France
    Cochin hospital, AP-HP
Nov 19, 2021

Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)

Completed
Has Results
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Epacadostat 25 mg
  • +7 more
  • (no location specified)
Aug 17, 2022

Vancomycin, Adult, Area Under Curve Trial in Greenfield Park (Vancomycin dose adjustment using the Bayesian method, Vancomycin

Completed
  • Vancomycin
  • +2 more
  • Vancomycin dose adjustment using the Bayesian method
  • Vancomycin dose adjustment using the trough level method
  • Greenfield Park, Quebec, Canada
    Charles-Le Moyne Hospital
Sep 9, 2021

Parkinson Disease Trial in Warsaw (Fecal Microbiota Transfer)

Enrolling by invitation
  • Parkinson Disease
  • Fecal Microbiota Transfer
  • Warsaw, Poland
    Department of Neurology, Faculty of health sciences, Medical Uni
Jan 10, 2022

Informed preciSion doSIng tO iNdividualise and Optimize

Not yet recruiting
  • Pharmacokinetics
  • +4 more
  • venipuncture
  • (no location specified)
Oct 16, 2023

COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol

Withdrawn
  • COPD
  • Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
  • Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
  • (no location specified)
Jan 19, 2022

ICU Predictive Score of WEaning Success in Patients At Risk of

Recruiting
  • Mechanical Ventilator Weaning
  • +12 more
    • Clermont-Ferrand, France
      CHU
    Jan 30, 2023

    Irritable Bowel Syndrome Trial in Nottingham (Psyllium, Methylcellulose, Maltodextrin)

    Recruiting
    • Irritable Bowel Syndrome
    • Psyllium
    • +2 more
    • Nottingham, Nottinghamshire, United Kingdom
      University Hospital Clinical Research Centre
    Jun 9, 2023

    Advanced Malignant Tumor Trial in Chengdu (QLF31907)

    Recruiting
    • Advanced Malignant Neoplasm
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital
    Dec 8, 2021

    Optimizing Vancomycin Therapy in Children

    Recruiting
    • Sepsis
    • +3 more
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Jan 17, 2023

      LSCI and Thermography in Diabetic Foot Patients Affected by

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • +2 more
        • (no location specified)
        Mar 30, 2023

        Influenza Infection Trial (Molnupiravir, Placebo molnupiravir, Placebo oseltamivir)

        Not yet recruiting
        • Influenza Infection
        • (no location specified)
        Apr 5, 2023

        Severe Hemophilia A Trial in Iran, Islamic Republic of (Factor VIII, recombinant human with Fc fusion (rFVIII-Fc))

        Completed
        • Severe Hemophilia A
        • Factor VIII, recombinant human with Fc fusion (rFVIII-Fc)
        • Isfahan, Iran, Islamic Republic of
        • +4 more
        Nov 13, 2023

        17-OHPC in Pregnancy: IM vs SC Routes

        Recruiting
        • Preterm Birth
        • 17-Hydroxyprogesterone Caproate 250 mg IM Dose
        • 17-Hydroxyprogesterone Caproate 275 mg SC Dose
        • Newark, Delaware
        • +3 more
        Feb 2, 2022

        A Novel Nomogram to Predict Postoperative Overall Survival in

        Completed
        • Gastrointestinal Cancers - Stomach
        • +4 more
        • observation
        • Nanjing, Jiangsu, China
          Jinling Hospital
        Nov 25, 2022

        Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia
        • Los Angeles, California
        • +15 more
        Jul 29, 2022

        Multitask Deep Learning System at Spine Metastasis CT

        Not yet recruiting
        • To Evaluate the Spinal Instability Detection Performance of the DLS
        • Deep Learning System
        • (no location specified)
        May 31, 2022

        Advanced/Metastatic NSCLC Trial in Worldwide (Ixabepilone, 32 mg/m^2, Paclitaxel, 200 mg/m^2, Carboplatin (area under the

        Completed
        Has Results
        • Advanced/Metastatic Non-Small Cell Lung Cancer
        • Ixabepilone, 32 mg/m^2
        • +2 more
        • La Jolla, California
        • +32 more
        Oct 6, 2020

        Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)

        Recruiting
        • Healthy
        • 5-MTHF glucosamine salt
        • +2 more
        • Saint-Herblain, France
          Biofortis
        Jan 31, 2023

        End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Trial in Edgewater, Tampa (MK-2060, Placebo)

        Recruiting
        • End-Stage Renal Disease
        • +2 more
        • MK-2060
        • Placebo
        • Edgewater, Florida
        • +1 more
        Jan 30, 2023

        Prediction of Radiation-induced Late Intestinal Injury

        Not yet recruiting
        • Radiation-induced Intestinal Injury
        • NCRT+TME
        • (no location specified)
        Feb 19, 2023

        Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)

        Completed
        Has Results
        • Respiratory Syncytial Viruses
        • Clesrovimab
        • +2 more
        • London, United Kingdom
          HVIVO Services Ltd ( Site 0001)
        Aug 29, 2022

        Liver Cirrhosis Trial (Rosuvastatin, Digoxin, Metformin hydrochlorid)

        Not yet recruiting
        • Liver Cirrhosis
        • (no location specified)
        Feb 27, 2023

        Chronicization of Radiation-induced Acute Intestinal Injury

        Not yet recruiting
        • Radiation-induced Intestinal Injury
        • NCRT+TME
        • (no location specified)
        Feb 19, 2023

        Alzheimer's Disease Trial in Changsha (AD16 5mg?10mg?20mg?30mg?40mg?60mg?80mg, AD16 5mg?10mg?20mg?30mg?40mg?60mg?80mg)

        Completed
        • Alzheimer's Disease
        • AD16 5mg、10mg、20mg、30mg、40mg、60mg、80mg
        • AD16 placebo 5mg、10mg、20mg、30mg、40mg、60mg、80mg
        • Changsha, China
          The Central South University Xiang Ya Hospital
        Mar 14, 2023